Relay Therapeutics
Stock Forecast, Prediction & Price Target
Relay Therapeutics Financial Estimates
Relay Therapeutics Revenue Estimates
Relay Therapeutics EBITDA Estimates
Relay Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $3.02M N/A | $1.38M -54.40% | $25.54M 1749.81% | Avg: $6.71M Low: $1.55M High: $11.86M avg. -73.72% | Avg: $41.28M Low: $35.58M High: $49.81M avg. 515.11% | Avg: $48.66M Low: $41.95M High: $58.73M avg. 17.89% | Avg: $132.25M Low: $114.00M High: $159.60M avg. 171.75% |
Net Income
% change YoY
| $-496.80M N/A | $-254.25M 48.82% | $-341.97M -34.49% | Avg: $-403.95M Low: $-420.43M High: $-297.86M avg. -18.12% | Avg: $-409.80M Low: $-395.92M High: $-230.44M avg. -1.44% | Avg: $-286.82M Low: $-363.93M High: $-235.37M avg. 30.00% | Avg: $-227.99M Low: $-289.28M High: $-187.08M avg. 20.51% |
EBITDA
% change YoY
| $-89.31M N/A | $-322.62M -261.22% | $-374.15M -15.97% | Avg: $-3.53M Low: $-6.24M High: $-819.21K avg. 99.05% | Avg: $-21.73M Low: $-26.22M High: $-18.73M avg. -515.11% | Avg: $-25.61M Low: $-30.91M High: $-22.08M avg. -17.89% | Avg: $-69.62M Low: $-84.01M High: $-60.01M avg. -171.75% |
EPS
% change YoY
| -$5.22 N/A | -$2.27 56.51% | -$2.79 -22.90% | Avg: -$2.88 Low: -$3.43 High: -$2.43 avg. -3.32% | Avg: -$2.65 Low: -$3.23 High: -$1.88 avg. 7.94% | Avg: -$2.34 Low: -$2.97 High: -$1.92 avg. 11.82% | Avg: -$1.86 Low: -$2.36 High: -$1.53 avg. 20.51% |
Operating Expenses
% change YoY
| $230.03M N/A | $312.33M 35.77% | $398.54M 27.60% | Avg: $95.46M Low: $22.13M High: $168.78M avg. -76.04% | Avg: $587.19M Low: $506.15M High: $708.62M avg. 515.11% | Avg: $692.25M Low: $596.71M High: $835.40M avg. 17.89% | Avg: $1.88B Low: $1.62B High: $2.27B avg. 171.75% |
FAQ
What is Relay Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 7.73% in 2025-2028.
We have gathered data from 10 analysts. Their low estimate is -420.43M, average is -403.95M and high is -297.86M.
What is Relay Therapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 157.75% in 2025-2028.
We have gathered data from 7 analysts. Their low revenue estimate is $1.55M, average is $6.71M and high is $11.86M.
What is Relay Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 9.23% in 2025-2028.
We have gathered data from 10 analysts. Their low earnings per share estimate is -$3.43, average is -$2.88 and high is $-2.43.
What is the best performing analyst?
In the last twelve months analysts have been covering Relay Therapeutics stock. The most successful analyst is Matt Biegler.